Skip to main content
NTRA
NASDAQ Industrial Applications And Services

Stockholders Approve 3.2 Million Share Increase for Equity Incentive Plan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$219.56
Mkt Cap
$31.523B
52W Low
$131.811
52W High
$256.36
52W Position info
67% above low
Off High info
14% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

NTRA sits 67% above its 52-week low of $131.811.

Summary

Natera's stockholders approved an amendment to its equity incentive plan, authorizing an additional 3.2 million shares for future awards, representing a potential dilution of over 2% of outstanding shares.


Key Events · Financing and Capital Events · NTRA

  • Stock Plan Amendment Approved

    Stockholders approved an amendment to the 2015 Equity Incentive Plan, increasing the shares reserved for issuance by 3.2 million shares of common stock.

  • Potential Dilution

    The 3.2 million additional shares represent approximately 2.24% of the company's currently outstanding common stock, creating potential for future dilution.

  • Annual Meeting Results

    Stockholders also re-elected directors, ratified Ernst & Young LLP as the independent auditor, and approved the advisory vote on executive compensation and its frequency.


Analysis · NTRA · Industrial Applications And Services

Natera's stockholders approved an amendment to its 2015 Equity Incentive Plan, authorizing an additional 3.2 million shares for future equity awards. This action, which finalizes a proposal from April 23, 2026, represents a potential dilution of approximately 2.24% of the current outstanding shares. While this provides the company with flexibility for employee compensation and retention, it also creates an overhang of potential future dilution for existing shareholders.

At the time of this filing, NTRA was trading at $219.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $31.5B. The 52-week trading range was $131.81 to $256.36. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NTRA - Latest Insights

NTRA
Jul 22, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $262.09
Real-time Price: $267.76 info
Change: +$5.67 (+2%) info
Market Cap: $38.347B info
NTRA
Jul 16, 2026, 6:35 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $270.65
Real-time Price: $267.76 info
Change: -$2.89 (-1%) info
Market Cap: $38.347B info
NTRA
Jun 24, 2026, 3:01 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $235.06
Real-time Price: $267.76 info
Change: +$32.70 (+14%) info
Market Cap: $38.347B info
NTRA
May 20, 2026, 7:09 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $197.59
Real-time Price: $267.76 info
Change: +$70.17 (+36%) info
Market Cap: $38.347B info
NTRA
May 19, 2026, 6:09 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $197.75
Real-time Price: $267.76 info
Change: +$70.01 (+35%) info
Market Cap: $38.347B info